Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1990 | 03-1990 | 12-1989 | 09-1989 | 06-1989 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 308 | 87 | 305 | 646 | 1,047 |
| Receivables | 33 | 43 | 20 | 64 | 128 |
| Inventories | 55 | 62 | 78 | 186 | 183 |
| Other current assets | 20 | 44 | 84 | 98 | 100 |
| TOTAL | $416 | $235 | $486 | $994 | $1,458 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 0 | 6 | 6 |
| Other Non-Current Assets | 4 | 4 | 4 | 4 | 4 |
| TOTAL | $4 | $4 | $4 | $10 | $10 |
| Total Assets | $527 | $357 | $618 | $1,230 | $1,733 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 75 | 93 | 124 | 117 | 112 |
| Accrued Expenses | 6 | 6 | 7 | 21 | 21 |
| Other current liabilities | 30 | 60 | 30 | 0 | 30 |
| TOTAL | $111 | $159 | $160 | $138 | $163 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,500 | 1,500 | 1,500 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 1,500 | 1,500 |
| TOTAL | $1,500 | $1,500 | $1,500 | $1,500 | $1,500 |
| Total Liabilities | $1,611 | $1,659 | $1,660 | $1,638 | $1,663 |
| Shareholders' Equity | |||||
| Common Shares | 70 | 25 | 25 | 25 | 25 |
| Retained earnings | -16,383 | -16,127 | -15,861 | -15,232 | -14,755 |
| Other shareholders' equity | 519 | 574 | 619 | 642 | 630 |
| TOTAL | $-1,084 | $-1,302 | $-1,042 | $-408 | $71 |
| Total Liabilities And Equity | $527 | $357 | $618 | $1,230 | $1,733 |